Contact Us
Drug Search Results
More Filters [+]

Pyronaridine

Alternative Names: pyronaridine
Latest Update: 2024-12-06
Latest Update Note: Clinical Trial Update

Product Description

Pyronaridine (PYR) is an erythrocytic schizonticide with a potent antimalarial activity against multidrug-resistant Plasmodium. The drug is used in combination with artesunate for the treatment of uncomplicated P. falciparum malaria, in adults and children. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/33280083/)

Mechanisms of Action: Hematin Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Philippines | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Shin Poong
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pyronaridine

Countries in Clinic: Burkina Faso, Gabon, Gambia, Kenya, Korea, Mozambique, Uganda, United Kingdom, Zambia

Active Clinical Trial Count: 4

Highest Development Phases

Phase 2: COVID-19|Communicable Diseases|Malaria|Malaria, Falciparum

Phase 1: Pregnancy Outcomes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CAPTURE 1

P2

Active, not recruiting

Malaria, Falciparum

2024-12-01

CAPTURE-2

P2

Recruiting

Communicable Diseases|Malaria

2024-11-30

SP-PA-COV-204

P2

Completed

COVID-19

2022-09-06

25%
MMV_SMC_21_01

P1

Completed

Malaria|Pregnancy Outcomes

2022-05-31

Recent News Events

Date

Type

Title

05/09/2024

PubMed

 Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum.

04/16/2024

PubMed

 Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood.

04/01/2024

PubMed

 Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.

09/18/2023

News Article

 Vietnam Artemisinin Combination Therapy Market Size, Trends, Growth Statistics, Share, and Forecast to 2023 to 2032

05/12/2022

News Article

 Insights on the Artemisinin Combination Therapy Global Market to 2027 - Growing R&D of New Therapies Presents Opportunities - ResearchAndMarkets.com

12/29/2021

News Article

 Artemisinin Combination Therapy Market Key Insights Based on Product Type, End-use and Regional Demand

05/07/2021

News Article

 Artemisinin Combination Therapy Market Size, Growth Outlook 2020-2025, Demand, Evolving Technology, Boost Efficiency, Top Companies

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions